Biktarvy, formally known as biktarvy, is a powerful single-tablet treatment for controlling HIV infection. This drug integrates three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the HIV's ability to multiply within the body, remarkably reducing the viral load. For many individuals, Biktarvy